Abstract:PURPOSE To retrospectively determine the relationship between apparent diffusion coefficients (ADCs) obtained with 3.0-T diffusion-weighted (DW) magnetic resonance (MR) imaging and Gleason grades in peripheral zone prostate cancer. MATERIALS AND METHODS The requirement to obtain institutional review board approval was waived. Fifty-one patients with prostate cancer underwent MR imaging before prostatectomy, including DW MR imaging with b values of 0, 50, 500, and 800 sec/mm(2). In prostatectomy specimens, separate slice-by-slice determinations of Gleason grade groups were performed according to primary, secondary, and tertiary Gleason grades. In addition, tumors were classified into qualitative grade groups (low-, intermediate-, or high-grade tumors). ADC maps were aligned to step-sections and regions of interest annotated for each tumor slice. The median ADC of tumors was related to qualitative grade groups with linear mixed-model regression analysis. The accuracy of the median ADC in the most aggressive tumor component in the differentiation of low- from combined intermediate- and high-grade tumors was summarized by using the area under the receiver operating characteristic (ROC) curve (A(z)). RESULTS In 51 prostatectomy specimens, 62 different tumors and 251 step-section tumor lesions were identified. The median ADC in the tumors showed a negative relationship with Gleason grade group, and differences among the three qualitative grade groups were statistically significant (P < .001). Overall, with an increase of one qualitative grade group, the median ADC (±standard deviation) decreased 0.18 × 10(-3) mm(2)/sec ± 0.02. Low-, intermediate-, and high-grade tumors had a median ADC of 1.30 × 10(-3) mm(2)/sec ± 0.30, 1.07 × 10(-3) mm(2)/sec ± 0.30, and 0.94 × 10(-3) mm(2)/sec ± 0.30, respectively. ROC analysis showed a discriminatory performance of A(z) = 0.90 in discerning low-grade from combined intermediate- and high-grade lesions. CONCLUSION ADCs at 3.0 T showed an inverse relationship to Gleason grades in peripheral zone prostate cancer. A high discriminatory performance was achieved in the differentiation of low-, intermediate-, and high-grade cancer.

Two New Xanthones from Hypericum Japonicum

Xanthones from hypericum japonicum and H. henryi

Constituents of Hypericum japonicum

Hyjapones A-D, trimethylated acyphloroglucinol meroterpenoids from Hypericum japonicum thunb. With anti-inflammatory activity

Two New Bioactive Α-Pyrones from Hypericum Japonicum

Hyperinoids A and B, Two Polycyclic Meroterpenoids from Hypericum Patulum

Urolithiasis in a children’s hospital: 1985–1990

Regulation of the signal transduction program by drugs.

Benzophenone Rhamnosides and Chromones from Hypericum seniawinii Maxim

A new dihydrodibenzodioxinone from Hypericum x 'Hidcote'

A BamHI RFLP in the human arylsulfatase A gene.

Two New Secondary Metabolites from Xylaria Sp. Cfcc 87468.

Undescribed Meroterpenoids from Hypericum japonicum with Neuroprotective Effects on H 2 O 2 Insult SH‐SY5Y Cells Targeting Keap1‐Nrf2

Two New 18-Norschiartane-type Schinortriterpenoids from Schisandra lancifolia.

Two rearranged acylphloroglucinols with moderate neuroprotective effects from Hypericum ascyron Linn.

Enantiomeric pairs of meroterpenoids with 11/5/6 spiro-heterocyclic systems from Hypericum kouytchense

Stilbenoids from the Roots of Stemona Tuberosa

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.

Xanthine oxidase inhibitory constituents from the roots of Ampelopsis japonica

Two New Xanthone Glycosides from Polygala Tenuifolia

Structure elucidation of two new xanthone derivatives from the marine fungus Penicillium sp. (ZZF 32#) from the South China Sea